Save
Email
Print
Share
RSSBrowse News Stories
51 to 60 of 980 stories
view headlines only
-
Genetic Defect in Sex Cells May Predispose to Childhood Leukemia
December 17, 2012 — Researchers have found a possible heredity mechanism that predisposes children to acute lymphoblastic leukemia (ALL), the most common type of blood cancer in children. The presence of a genetic ... > full story -
New Biomarker for Bone Marrow Cancer: Discovery Suggests New Ways of Treating Multiple Myeloma
December 13, 2012 — Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form ... > full story -
Vegetable Compound Could Become Ingredient to Treating Leukemia
December 12, 2012 — A concentrated form of a compound called sulforaphane found in broccoli and other cruciferous vegetables has been shown to reduce the number of acute lymphoblastic leukemia cells in the lab setting, ... > full story -
Older and Younger Chronic Leukemia Patients May Need Different Therapy
December 12, 2012 — Age is usually not considered when determining treatment for people with chronic lymphocytic leukemia (CLL), but a new study indicates that older patients with CLL may require different therapy than ... > full story -
Intensified Chemotherapy Shows Promise for Children With Very High Risk Form of Leukemia
December 10, 2012 — Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, ... > full story -
Experimental Graft-Versus-Host Disease Treatment Equivalent to Standard Care in Phase 3 Trial
December 10, 2012 — Researchers found an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could ... > full story -
Leukemia
Diseases and Conditions
Lymphoma
Wounds and Healing
Today's Healthcare
Multiple Sclerosis Research
Drug Combination Acts Against Aggressive Chronic Lymphocytic Leukemia
December 10, 2012 — A two-prong approach combining ibrutinib and rituximab (Rituxin®) to treat aggressive chronic lymphocytic leukemia (CLL) produced profound responses with minor side effects in a Phase 2 clinical ... > full story -
Leukemia Patients Remain in Remission More Than Two Years After Engineered T Cell Therapy
December 10, 2012 — Nine of 12 leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the ... > full storyMore: -
Leukemia
Osteoporosis
Today's Healthcare
Diseases and Conditions
Wounds and Healing
Multiple Sclerosis Research
Reduced Intensity Regimen Prior to Marrow Transplant Better for Older Leukemia Patients, Study Suggests
December 9, 2012 — A new study shows that preparing older acute myeloid leukemia patients for bone marrow transplants with a reduced intensity conditioning regimen appears to be associated with higher rates of ... > full story -
Scientists Target DNA Repair to Eradicate Leukemia Stem Cells
December 9, 2012 — Despite treatment with imatinib, which targets chronic myeloid leukemia, some patients may be at risk for relapse because of leukemia stem cells that are resistant to treatment, accumulating ... > full story
Search ScienceDaily
Number of stories in archives: 137,088
more 
